Uganda's Sickle Cell Patients At Risk As Asthma Goes Undetected

A compelling case from Uganda, presented during the Day of Lung Science webinar hosted by the Makerere Lung Institute, has brought to light a critical diagnostic challenge: the frequent misidentification of asthma in patients suffering from sickle cell disease. The story of a 16-year-old girl, initially treated for a persistent chest infection that failed to respond to antibiotics, underscores the potentially life-threatening consequences of this diagnostic overlap.

According to Dr. Joanita Nampijja, a pediatrician involved in the case, the teenager's respiratory symptoms were initially attributed to common sickle cell complications. However, the persistent cough that did not resolve even with intensive treatment prompted further investigation. It was a spirometry test, a measure of lung function, that finally revealed the underlying asthma, a condition that had been hiding in plain sight. Once treated with an inhaler, the patient stabilized, highlighting the crucial role of accurate diagnosis.

“

When she presented with respiratory symptoms, the working diagnosis followed a familiar path: infection, possibly early complications of sickle cell disease.

This case is not an isolated incident but reflects a broader issue within Uganda's healthcare system. Dr. Deogratias Munube, a pediatric hematologist, explained that both sickle cell disease and asthma share biological links through disruptions in nitric oxide pathways, leading to similar clinical manifestations. This convergence means that patients with both conditions are at a higher risk of severe respiratory distress. The challenge for Ugandan clinicians lies in distinguishing asthma from more typical sickle cell crises, a task made more difficult by limited access to advanced diagnostic tools like spirometry in many settings. This situation demands greater awareness and targeted training to ensure that patients receive timely and appropriate care, preventing potentially fatal outcomes.

“

The two conditions operate through different mechanisms but converge on similar outcomes. Patients with both conditions are more likely to experience severe respiratory distress and complications than those with either condition alone.